ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 159 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,082,674 | -3.9% | 114,521 | +8.1% | 0.00% | 0.0% |
| Q2 2023 | $4,249,277 | 0.0% | 105,967 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,249,277 | -24.8% | 105,967 | -13.1% | 0.00% | -33.3% |
| Q4 2022 | $5,648,506 | -99.9% | 121,919 | +23.6% | 0.00% | +50.0% |
| Q3 2022 | $4,084,559,000 | -40.3% | 98,637 | -14.0% | 0.00% | -50.0% |
| Q2 2022 | $6,841,570,000 | -18.2% | 114,676 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $8,364,591,000 | -3.9% | 115,183 | +11.3% | 0.00% | +33.3% |
| Q4 2021 | $8,704,492,000 | +4.1% | 103,514 | +11.6% | 0.00% | 0.0% |
| Q3 2021 | $8,361,785,000 | -8.0% | 92,713 | -2.7% | 0.00% | -25.0% |
| Q2 2021 | $9,084,090,000 | +10.0% | 95,271 | +31.4% | 0.00% | 0.0% |
| Q1 2021 | $8,256,787,000 | -12.8% | 72,517 | +6.0% | 0.00% | 0.0% |
| Q4 2020 | $9,468,750,000 | +76.3% | 68,401 | +4.7% | 0.00% | +33.3% |
| Q3 2020 | $5,369,885,000 | +14.2% | 65,335 | +8.7% | 0.00% | 0.0% |
| Q2 2020 | $4,700,866,000 | +75.1% | 60,098 | -0.5% | 0.00% | +50.0% |
| Q1 2020 | $2,683,927,000 | +5.8% | 60,408 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $2,537,829,000 | +2.1% | 59,420 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $2,484,834,000 | -19.1% | 58,084 | +20.2% | 0.00% | 0.0% |
| Q2 2019 | $3,069,592,000 | +1.1% | 48,340 | +10.5% | 0.00% | 0.0% |
| Q1 2019 | $3,035,401,000 | +96.9% | 43,763 | +23.5% | 0.00% | +100.0% |
| Q4 2018 | $1,541,323,000 | -40.2% | 35,449 | +5.0% | 0.00% | -50.0% |
| Q3 2018 | $2,578,230,000 | +1.1% | 33,773 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $2,549,777,000 | +49.6% | 33,170 | -0.8% | 0.00% | +100.0% |
| Q1 2018 | $1,704,596,000 | +37.8% | 33,430 | +25.4% | 0.00% | 0.0% |
| Q4 2017 | $1,236,584,000 | -7.2% | 26,662 | +6.5% | 0.00% | 0.0% |
| Q3 2017 | $1,332,885,000 | -9.2% | 25,026 | +5.9% | 0.00% | 0.0% |
| Q2 2017 | $1,468,032,000 | +9.2% | 23,636 | +19.1% | 0.00% | 0.0% |
| Q1 2017 | $1,344,823,000 | +150327.6% | 19,841 | +56.1% | 0.00% | 0.0% |
| Q4 2016 | $894,000 | -40.9% | 12,713 | -40.4% | 0.00% | -50.0% |
| Q3 2016 | $1,513,000 | +57.3% | 21,319 | +8.4% | 0.00% | +100.0% |
| Q2 2016 | $962,000 | +24.9% | 19,659 | +61.6% | 0.00% | 0.0% |
| Q1 2016 | $770,000 | -88.6% | 12,167 | -79.8% | 0.00% | -87.5% |
| Q4 2015 | $6,747,000 | +15.0% | 60,146 | -1.2% | 0.01% | +33.3% |
| Q3 2015 | $5,866,000 | +496.7% | 60,907 | +534.4% | 0.01% | +500.0% |
| Q2 2015 | $983,000 | +95.4% | 9,600 | +18.5% | 0.00% | – |
| Q1 2015 | $503,000 | +149.0% | 8,100 | +76.1% | 0.00% | – |
| Q4 2014 | $202,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |